Paper355604
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.
Walker MD and 11 others. J Neurosurg, 1978. Cited by 1,405 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. Papers, record 355604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/355604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Carmustine | Major topic |
| Glioma | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Child | |
| Clinical Trials as Topic | |
| Evaluation Studies as Topic | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06831773 | Clinical Study of Carbon Ion Radiotherapy for High-grade Glioma | Background |
Source ClinicalTrials.gov
Cited by432
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,405 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42506372 | When Surgical Innovation Outpaces Evidence: Does Modern Maximal Resection Require Re-Evaluation of Postoperative Radiotherapy in Glioblastoma? | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42506372 | PubMed |
| 42465896 | Phase I dose escalation of the Exportin 1 inhibitor, Selinexor, in combination with chemoradiation in patients with newly diagnosed glioblastoma. | medRxiv | 2026 | https://conductscience.org/library/papers/42465896 | PubMed |
| 42286261 | Spatial-temporal recurrence patterns of grade 4 glioma using deep learning integrated multiparametric MRI and molecular pathology. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42286261 | PubMed |
| 42281979 | DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types. | Res Sq | 2026 | https://conductscience.org/library/papers/42281979 | PubMed |
| 42222273 | The evolution of chemotherapy in brain tumors: from historical milestones to precision medicine in glioblastoma. | Explor Target Antitumor Ther | 2026 | https://conductscience.org/library/papers/42222273 | PubMed |
| 42111034 | Comparative analysis of outcome, recurrence patterns, and dosimetry in glioblastoma patients treated according to RTOG versus EORTC contouring guidelines. | Neurooncol Pract | 2026 | https://conductscience.org/library/papers/42111034 | PubMed |
| 42031827 | Prognostic determinants and predictive modeling in higher-grade glioma patients receiving radiotherapy: a retrospective SEER-based study. | Sci Rep | 2026 | https://conductscience.org/library/papers/42031827 | PubMed |
| 41851195 | NANP targeting radiosensitizes glioblastoma through TNFR1 sialylation-driven mesenchymal shift. | Nat Commun | 2026 | https://conductscience.org/library/papers/41851195 | PubMed |
| 41684714 | Innovative radiotherapies for the treatment of glioblastoma. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/41684714 | PubMed |
| 41632520 | Reply to: Blood-Brain Barrier Heterogeneity in NRG BN007: Implications for Immunotherapy Delivery. | J Clin Oncol | 2026 | https://conductscience.org/library/papers/41632520 | PubMed |
| 41501375 | The functional imperative in high-grade glioma. | Exp Mol Med | 2026 | https://conductscience.org/library/papers/41501375 | PubMed |
| 40985888 | Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma. | JCI Insight | 2025 | https://conductscience.org/library/papers/40985888 | PubMed |
| 40867234 | The Effects of Radiation Therapy on the Ocular Apparatus: Implications for Management. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40867234 | PubMed |
| 40852066 | Comparison of Quality of Life in Postoperative High-Grade Glioma Patients Treated Using EORTC and RTOG Target Delineation Techniques for Postoperative Radiotherapy. | Asian J Neurosurg | 2025 | https://conductscience.org/library/papers/40852066 | PubMed |
| 39595047 | Amino Acid Deprivation in Glioblastoma: The Role in Survival and the Tumour Microenvironment-A Narrative Review. | Biomedicines | 2024 | https://conductscience.org/library/papers/39595047 | PubMed |
| 39468721 | Sleep disorders associated with cranial radiation-A systematic review. | Neuro Oncol | 2025 | https://conductscience.org/library/papers/39468721 | PubMed |
| 39375777 | In vivo perturb-seq of cancer and microenvironment cells dissects oncologic drivers and radiotherapy responses in glioblastoma. | Genome Biol | 2024 | https://conductscience.org/library/papers/39375777 | PubMed |
| 39239570 | A systematic review of normal tissue neurovascular unit damage following brain irradiation-Factors affecting damage severity and timing of effects. | Neurooncol Adv | 2024 | https://conductscience.org/library/papers/39239570 | PubMed |
| 38994761 | Targeting drug resistance in glioblastoma (Review). | Int J Oncol | 2024 | https://conductscience.org/library/papers/38994761 | PubMed |
| 38899374 | Current status of precision oncology in adult glioblastoma. | Mol Oncol | 2024 | https://conductscience.org/library/papers/38899374 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/355604
GET https://conductscience.org/api/papers/v1/355604/cited_by?page=2